Dediabetes Logo
Questions
Published answers connected to evidence
Clinical Reference
Detailed intervention and outcome dossiers
Latest Research
Newest studies
About
How deDiabetes works
Settings
Login / Sign-up
Research Summary
Analyzed using Evidence Intelligence™

POLYCHEM shows no superiority over standard care for diabetes remission

Powered by the Dediabetes Evidence Intelligence™ framework

Last updated September 12, 2026

Key finding

After 16 weeks, 54 (90.0%) patients in the POLYCHEM arm achieved regression of diabetic hyperglycemia compared to 37 (77.1%) in the SDC arm (p = 0.002).

This study compared a four-drug regimen (POLYCHEM) to standard diabetes care (SDC) in newly diagnosed type 2 diabetes patients, finding no significant difference in diabetes remission but a notable improvement in hyperglycemia regression with POLYCHEM.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

High Risk

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study compared a four-drug regimen (POLYCHEM) to standard diabetes care (SDC) in newly diagnosed type 2 diabetes patients, finding no significant difference in diabetes remission but a notable improvement in hyperglycemia regression with POLYCHEM.

Clinical relevance

These findings suggest that while both treatment options can lead to remission, POLYCHEM may offer additional benefits in managing hyperglycemia, which is crucial for long-term diabetes control. This could influence treatment choices for newly diagnosed patients.

Keep in mind

The study may have limited generalizability due to the specific population enrolled. Effectiveness measures were not uniformly clear across all outcomes. Sample sizes for some outcomes were relatively small.

Published in

Journal Reference

Publication details and source links for this paper.

Alessandra DC, Raffaella A, Giuseppe M, et al. A four-drug regimen (POLYCHEM) vs. standard diabetes care (SDC) in newly diagnosed type 2 diabetes. Journal of Endocrinological Investigation. 2026;49(9):2521-2531. doi:10.1007/s40618-026-02930-3

View DOIView on PubMedView on PMC

Main Effects

At visit 3, 23 (38.3%) patients in the POLYCHEM arm achieved diabetes remission compared to 21 (43.8%) in the SDC arm (p = 0.59).

After 16 weeks, 54 (90.0%) patients in the POLYCHEM arm achieved regression of diabetic hyperglycemia compared to 37 (77.1%) in the SDC arm (p = 0.002).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to POLYCHEM, Standard face-to-face care and Diabetes remission, Odds ratio for response in glycated hemoglobin screening.

This study contributes evidence to

Intervention

POLYCHEM

Outcome

Diabetes remission

Evidence topic

Diabetes Remission

Primary intervention

POLYCHEM

Primary outcomes

  • Diabetes remission
  • Odds ratio for response in glycated hemoglobin screening

Evidence topics

Diabetes Remission

Primary intervention

POLYCHEM

Primary outcomes

Diabetes remissionOdds ratio for response in glycated hemoglobin screening

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

4
Evidence pairs
4
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 63

1

Related topics

4

Evidence pairs

21

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 4 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

Diabetes Remission

matched_outcome

Core evidence

Study findings

The primary outcomes reported in this study.

Diabetes remission

POLYCHEM → Diabetes remission

POLYCHEM → Diabetes remission

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Odds ratio for response in glycated hemoglobin screening

POLYCHEM → Odds ratio for response in glycated hemoglobin screening

POLYCHEM → Odds ratio for response in glycated hemoglobin screening

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
25
Negative
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Diabetes remission

Standard face-to-face care → Diabetes remission

Standard face-to-face care → Diabetes remission

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Odds ratio for response in glycated hemoglobin screening

Standard face-to-face care → Odds ratio for response in glycated hemoglobin screening

Standard face-to-face care → Odds ratio for response in glycated hemoglobin screening

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
25
Negative
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • POLYCHEM led to 90% regression of hyperglycemia compared to 77.1% with SDC (p = 0.002).
  • Remission rates were similar: 38.3% for POLYCHEM vs. 43.8% for SDC (p = 0.59).
who this applies

Who this applies to

  • Adults newly diagnosed with type 2 diabetes.
  • Patients seeking alternative treatment options for diabetes management.
keep in mind

Keep in Mind

  • Results may not apply to populations outside the study's demographic.
  • Further research is needed to confirm long-term benefits of POLYCHEM.
  • The statistical significance of remission rates was not achieved.
between the lines

Between the Lines

  • The study may have limited generalizability due to the specific population enrolled.
  • Effectiveness measures were not uniformly clear across all outcomes.
  • Sample sizes for some outcomes were relatively small.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Powered by the Dediabetes Evidence Intelligence™ framework

This study contributes to evidence on POLYCHEM and Diabetes Remission, POLYCHEM and Odds ratio for response in glycated hemoglobin screening.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does POLYCHEM improve diabetes remission?

Emerging Evidence

Current evidence does not show a clear benefit of POLYCHEM for diabetes remission.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Diabetes remission

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence

Does Standard face-to-face care improve diabetes remission?

Emerging Evidence

Current evidence does not show a clear benefit of Standard face-to-face care for diabetes remission.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Diabetes remission

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence

Does POLYCHEM lower odds ratio for response in glycated hemoglobin screening?

Emerging Evidence

POLYCHEM may worsen odds ratio for response in glycated hemoglobin screening or be associated with harm.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Odds ratio for response in glycated hemoglobin screening

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence

Does Standard face-to-face care lower odds ratio for response in glycated hemoglobin screening?

Emerging Evidence

Standard face-to-face care may worsen odds ratio for response in glycated hemoglobin screening or be associated with harm.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Odds ratio for response in glycated hemoglobin screening

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

Diabetes Remission Evidence Hub

Explore in Evidence Explorer

Open broader Evidence Explorer views for this relationship.

All studies on POLYCHEM and Diabetes remissionAll studies on Standard face-to-face care and Diabetes remissionAll studies on POLYCHEM and Odds ratio for response in glycated hemoglobin screeningAll studies on Standard face-to-face care and Odds ratio for response in glycated hemoglobin screening

Related research

Read related research summaries.

Bariatric surgery improves type 2 diabetes remission through gut microbiota changesDietary interventions improve diabetes remission ratesGlycated Hemoglobin Screening Improves Diabetes Identification in South AsiansIntegrated data platform improves diabetes management in adults.Low-calorie diets may improve diabetes remission in Chinese adults

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.